Envelope-deforming antiviral peptide derived from influenza virus M2 protein. 2019

Younghun Jung, and Byoungjae Kong, and Seokoh Moon, and Seok-Hyeon Yu, and Jinhyo Chung, and Choongjin Ban, and Woo-Jae Chung, and Sung-Gun Kim, and Dae-Hyuk Kweon
Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon, 16419, Republic of Korea.

Molecules interfering with lipid bilayer function exhibit strong antiviral activity against a broad range of enveloped viruses, with a lower risk of resistance development than that for viral protein-targeting drugs. Amphipathic peptides are rich sources of such membrane-interacting antivirals. Here, we report that influenza viruses were effectively inactivated by M2 AH, an amphipathic peptide derived from the M2 protein of the influenza virus. Although overall hydrophobicity (<H>) of M2 AH was not related to antiviral activity, modification of the hydrophobic moment (<μH>) of M2 AH dramatically altered the antiviral activity of this peptide. M2 MH, a derivative of M2 AH with a <μH> of 0.874, showed a half maximal inhibitory concentration (IC50) of 53.3 nM against the A/PR/8/34 strain (H1N1), which is 16-times lower than that of M2 AH. The selectivity index (IC50/CC50), where CC50 is the half maximal cytotoxic concentration, was 360 for M2 MH and 81 for M2 AH. Dynamic light scattering spectroscopy and electron microscopy revealed that M2 AH-derived peptides did not disrupt liposomes but altered the shape of viruses. This result suggests that the shape of virus envelope was closely related to its activity. Thus, we propose that deforming without rupturing the membranes may achieve a high selectivity index for peptide antivirals.

UI MeSH Term Description Entries
D008051 Lipid Bilayers Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes. Bilayers, Lipid,Bilayer, Lipid,Lipid Bilayer
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014763 Viral Matrix Proteins Proteins associated with the inner surface of the lipid bilayer of the viral envelope. These proteins have been implicated in control of viral transcription and may possibly serve as the "glue" that binds the nucleocapsid to the appropriate membrane site during viral budding from the host cell. Membrane Proteins, Viral,Viral M Proteins,Viral M Protein,Viral Membrane Proteins

Related Publications

Younghun Jung, and Byoungjae Kong, and Seokoh Moon, and Seok-Hyeon Yu, and Jinhyo Chung, and Choongjin Ban, and Woo-Jae Chung, and Sung-Gun Kim, and Dae-Hyuk Kweon
May 1966, Journal of bacteriology,
Younghun Jung, and Byoungjae Kong, and Seokoh Moon, and Seok-Hyeon Yu, and Jinhyo Chung, and Choongjin Ban, and Woo-Jae Chung, and Sung-Gun Kim, and Dae-Hyuk Kweon
June 2020, Veterinary microbiology,
Younghun Jung, and Byoungjae Kong, and Seokoh Moon, and Seok-Hyeon Yu, and Jinhyo Chung, and Choongjin Ban, and Woo-Jae Chung, and Sung-Gun Kim, and Dae-Hyuk Kweon
October 2019, Nature communications,
Younghun Jung, and Byoungjae Kong, and Seokoh Moon, and Seok-Hyeon Yu, and Jinhyo Chung, and Choongjin Ban, and Woo-Jae Chung, and Sung-Gun Kim, and Dae-Hyuk Kweon
April 2006, Gene therapy,
Younghun Jung, and Byoungjae Kong, and Seokoh Moon, and Seok-Hyeon Yu, and Jinhyo Chung, and Choongjin Ban, and Woo-Jae Chung, and Sung-Gun Kim, and Dae-Hyuk Kweon
December 2017, International journal of molecular sciences,
Younghun Jung, and Byoungjae Kong, and Seokoh Moon, and Seok-Hyeon Yu, and Jinhyo Chung, and Choongjin Ban, and Woo-Jae Chung, and Sung-Gun Kim, and Dae-Hyuk Kweon
September 1970, Archives of environmental health,
Younghun Jung, and Byoungjae Kong, and Seokoh Moon, and Seok-Hyeon Yu, and Jinhyo Chung, and Choongjin Ban, and Woo-Jae Chung, and Sung-Gun Kim, and Dae-Hyuk Kweon
July 2009, Biochemistry,
Younghun Jung, and Byoungjae Kong, and Seokoh Moon, and Seok-Hyeon Yu, and Jinhyo Chung, and Choongjin Ban, and Woo-Jae Chung, and Sung-Gun Kim, and Dae-Hyuk Kweon
November 1990, Virology,
Younghun Jung, and Byoungjae Kong, and Seokoh Moon, and Seok-Hyeon Yu, and Jinhyo Chung, and Choongjin Ban, and Woo-Jae Chung, and Sung-Gun Kim, and Dae-Hyuk Kweon
May 1992, Cell,
Younghun Jung, and Byoungjae Kong, and Seokoh Moon, and Seok-Hyeon Yu, and Jinhyo Chung, and Choongjin Ban, and Woo-Jae Chung, and Sung-Gun Kim, and Dae-Hyuk Kweon
October 2009, Cell host & microbe,
Copied contents to your clipboard!